Skip to main content

Diabetic Neuropathy News

Neuropathy Nerve Damage Often Goes Undiagnosed

THURSDAY, May 9, 2024 — Though it is a widespread disorder, neuropathy often goes undiagnosed, new research shows, leaving many people at risk of falls, infection and even amputation. Neuropathy is n...

Averitas Pharma Announces FDA Approval of Qutenza for the Treatment of Neuropathic Pain Associated with Diabetic Peripheral Neuropathy of the Feet

AACHEN, Germany and MORRISTOWN, N.J., July 21, 2020 /PRNewswire/ – Grünenthal announced today that its U.S. subsidiary Averitas Pharma, Inc. received U.S. Food and Drug Administration (FDA) approval ...

FDA Approves Lyrica CR (pregabalin) Extended-Release Tablets for Neuropathic Pain Conditions

October 12, 2017 - Pfizer Inc. (NYSE: PFE) announced today that the United States Food and Drug Administration (FDA) has approved Lyrica CR (pregabalin) extended-release tablets CV as once-daily...

Ask a question

To post your own question to our community, sign in or create an account.

Further information

Related condition support groups

Diabetes Mellitus

Related drug support groups

gabapentin, Cymbalta, Lyrica, pregabalin, duloxetine, topiramate, nortriptyline